Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? A critical appraisal

OBJECTIVE: Arterial hypertension (HTN) is reported to burden up to 74% of systemic lupus erythematosus (SLE) patients and contributes significantly to accelerated atherosclerosis and increased cardiovascular (CV) risk. Current HTN treatment guidelines have not incorporated lupus patients in their recommendations; whether these guidelines can be fully implemented in SLE is doubtful. METHODS: A critical appraisal of the existing HTN guidelines in …